All PlansCoverageMedium impact
Recall: Accupril Tablets
UPMC Health Plan·Cardiology, Internal Medicine, Family Medicine +2 more·Pharmacy
We identified it
Aug 7, 2026
Summary
Pfizer is recalling specific batches of Accupril tablets (Quinapril HCl 10 mg, 20 mg, and 40 mg) due to contamination with N-nitrosoquinapril at levels exceeding acceptable daily intake limits. The billing team must identify affected prescriptions and coordinate with providers to transition patients to alternative medications or unaffected batches.
Action Required
Immediately: Clinical staff and providers must identify all active patients currently prescribed Accupril tablets from affected batches. Billing team should flag any claims submitted for recalled batches and be prepared to handle claim adjustments or reversals if necessary. Coordinate with pharmacy to confirm whether prescriptions should be switched to alternative ACE inhibitors or unaffected Accupril batches. Document all communications and claim status changes. Verify with UPMCHealthPlan for specific batch numbers and any claim reprocessing requirements to avoid denials.